Common use of Regulatory Milestone License Payment Clause in Contracts

Regulatory Milestone License Payment. Upon the Company’s notice to the Purchaser of the Company’s receipt from the FDA of final approval of the first NDA for the Product, the Purchaser shall pay within thirty (30) days of such final approval to the Company an additional one-time payment of Forty Million U.S. Dollars ($40,000,000) (the “Regulatory Milestone Payment”).

Regulatory Milestone License Payment. Upon the Company’s notice In addition to the Purchaser of Upfront License Payment, upon the CompanyPurchaser’s receipt from the FDA of final approval of the first NDA prepared by the Purchaser with respect to the Product for the Productany indication, the Purchaser shall pay within thirty (30) days of such final approval to the Company an additional one-time payment of Forty Fifteen Million U.S. Dollars ($40,000,00015,000,000) (the “Regulatory Milestone Payment”).